A double-blind, parallel design study to compare the effectiveness of eplerenone versus atenolol in reversing the remodeling of resistance arteries in subjects with mild to moderate primary hypertension
Phase of Trial: Phase III
Latest Information Update: 06 Sep 2006
At a glance
- Drugs Atenolol; Eplerenone
- Indications Essential hypertension; Hypertension
- Focus Pharmacodynamics
- 06 Sep 2006 Status change
- 06 Sep 2006 The expected completion date for this trial is now .
- 06 Nov 2005 New trial record.